Why the study?
Data on the usefulness of CMR imaging for clinical decision-making in patients with an ICD are scarce.
Does cardiovascular magnetic resonance imaging improve diagnostic stratification and treatment decisions in patients with implantable cardioverter defibrillators presenting with electrical instability or worsening heart failure symptoms?
Does cardiovascular magnetic resonance imaging improve diagnostic stratification and treatment decisions in patients with implantable cardioverter defibrillators presenting with electrical instability or worsening heart failure symptoms?
Answers are grounded in this paper and cite their sources.
CMR imaging provides significant diagnostic and management-changing information in ICD patients presenting with electrical instability or worsening heart failure symptoms.
BACKGROUND: Data on the usefulness of cardiovascular magnetic resonance (CMR) imaging for clinical decision making in patients with an implanted cardioverter defibrillator (ICD) are scarce. The present study determined the impact of CMR imaging on diagnostic stratification and treatment decisions in ICD patients presenting with electrical instability or progressive heart failure symptoms. METHODS: 212 consecutive ICD patients underwent 1.5 T CMR combining diagnostic imaging modules tailored to the individual clinical indication (ventricular function assessment, myocardial tissue characterization, adenosine stress-perfusion, 3D-contrast-enhanced angiography); four CMR examinations (4/212, 2%) were excluded due to non-diagnostic CMR image quality. The resultant change in diagnosis or clinical management was determined in the overall population and compared between ICD patients for primary (115/208, 55%) or secondary prevention (93/208, 45%). Referral indication consisted of documented ventricular tachycardia, inadequate device therapy or progressive heart failure symptoms. RESULTS: Overall, CMR imaging data changed diagnosis in 40% (83/208) with a significant difference between primary versus secondary prevention ICD patients (37/115, 32% versus 46/93, 49%, respectively; p = 0.01). The information gain from CMR led to an overall change in treatment in 21% (43/208) with a similar distribution in primary versus secondary prevention ICD patients (25/115,22% versus 18/93,19%, p = 0.67). The effect on treatment change was highest in patients initially scheduled for ventricular tachycardia ablation procedure (18/141, 13%) with revision of the treatment plan to medical therapy or coronary revascularization. CONCLUSIONS: CMR imaging in ICD patients presenting with electrical instability or worsening heart failure symptoms provided diagnostic or management-changing information in a considerable proportion (40% and 21%, respectively).
No takes yet. Share an insight, caveat, or question.
Lindemann et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: